{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T22:08:22Z","timestamp":1785276502609,"version":"3.55.0"},"publisher-location":"New York, NY","reference-count":110,"publisher":"Springer US","isbn-type":[{"value":"9781071622643","type":"print"},{"value":"9781071622650","type":"electronic"}],"license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022]]},"DOI":"10.1007\/978-1-0716-2265-0_3","type":"book-chapter","created":{"date-parts":[[2022,4,18]],"date-time":"2022-04-18T16:04:57Z","timestamp":1650297897000},"page":"37-54","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Stevens\u2013Johnson Syndrome and Toxic Epidermal Necrolysis in the Era of Systems Medicine"],"prefix":"10.1007","author":[{"given":"Chun-Bing","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuang-Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Hung","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,19]]},"reference":[{"issue":"19","key":"3_CR1","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1056\/NEJM199411103311906","volume":"331","author":"JC Roujeau","year":"1994","unstructured":"Roujeau JC, Stern RS (1994) Severe adverse cutaneous reactions to drugs. N Engl J Med 331(19):1272\u20131285. https:\/\/doi.org\/10.1056\/NEJM199411103311906","journal-title":"N Engl J Med"},{"issue":"1","key":"3_CR2","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1001\/archderm.1993.01680220104023","volume":"129","author":"S Bastuji-Garin","year":"1993","unstructured":"Bastuji-Garin S, Rzany B, Stern RS et al (1993) Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol 129(1):92\u201396","journal-title":"Arch Dermatol"},{"issue":"24","key":"3_CR3","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1056\/NEJM199512143332404","volume":"333","author":"JC Roujeau","year":"1995","unstructured":"Roujeau JC, Kelly JP, Naldi L et al (1995) Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med 333(24):1600\u20131607. https:\/\/doi.org\/10.1056\/NEJM199512143332404","journal-title":"N Engl J Med"},{"issue":"7","key":"3_CR4","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1111\/1346-8138.13430","volume":"43","author":"WH Chung","year":"2016","unstructured":"Chung WH, Wang CW, Dao RL (2016) Severe cutaneous adverse drug reactions. J Dermatol 43(7):758\u2013766. https:\/\/doi.org\/10.1111\/1346-8138.13430","journal-title":"J Dermatol"},{"issue":"2","key":"3_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2013.05.002","volume":"69","author":"RA Schwartz","year":"2013","unstructured":"Schwartz RA, McDonough PH, Lee BW (2013) Toxic epidermal necrolysis: part II. Prognosis, sequelae, diagnosis, differential diagnosis, prevention, and treatment. J Am Acad Dermatol 69(2):187.e181-116; quiz 203-184. https:\/\/doi.org\/10.1016\/j.jaad.2013.05.002","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"3_CR6","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1111\/j.1346-8138.2006.00142.x","volume":"33","author":"N Kamada","year":"2006","unstructured":"Kamada N, Kinoshita K, Togawa Y et al (2006) Chronic pulmonary complications associated with toxic epidermal necrolysis: report of a severe case with anti-Ro\/SS-A and a review of the published work. J Dermatol 33(9):616\u2013622. https:\/\/doi.org\/10.1111\/j.1346-8138.2006.00142.x","journal-title":"J Dermatol"},{"issue":"1","key":"3_CR7","doi-asserted-by":"publisher","first-page":"96","DOI":"10.5414\/ALX01508E","volume":"1","author":"M Mockenhaupt","year":"2017","unstructured":"Mockenhaupt M (2017) Epidemiology of cutaneous adverse drug reactions. Allergol Select 1(1):96\u2013108. https:\/\/doi.org\/10.5414\/ALX01508E","journal-title":"Allergol Select"},{"key":"3_CR8","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/1750-1172-5-39","volume":"5","author":"T Harr","year":"2010","unstructured":"Harr T, French LE (2010) Toxic epidermal necrolysis and Stevens-Johnson syndrome. Orphanet J Rare Dis 5:39. https:\/\/doi.org\/10.1186\/1750-1172-5-39","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"3_CR9","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/clpt.2009.252","volume":"88","author":"B Sassolas","year":"2010","unstructured":"Sassolas B, Haddad C, Mockenhaupt M et al (2010) ALDEN, an algorithm for assessment of drug causality in Stevens\u2013Johnson syndrome and toxic epidermal necrolysis: comparison with case\u2013control analysis. Clin Pharmacol Ther 88(1):60\u201368","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"3_CR10","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1002\/cpt.1071","volume":"105","author":"YH Wang","year":"2019","unstructured":"Wang YH, Chen CB, Tassaneeyakul W, Asian Severe Cutaneous Adverse Reaction C et al (2019) The medication risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in Asians: the major drug causality and comparison with the US FDA label. Clin Pharmacol Ther 105(1):112\u2013120. https:\/\/doi.org\/10.1002\/cpt.1071","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"3_CR11","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1080\/1744666X.2020.1740591","volume":"16","author":"CC Lin","year":"2020","unstructured":"Lin CC, Chen CB, Wang CW et al (2020) Stevens-Johnson syndrome and toxic epidermal necrolysis: risk factors, causality assessment and potential prevention strategies. Expert Rev Clin Immunol 16(4):373\u2013387. https:\/\/doi.org\/10.1080\/1744666X.2020.1740591","journal-title":"Expert Rev Clin Immunol"},{"issue":"12","key":"3_CR12","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1093\/infdis\/jit383","volume":"208","author":"WH Chung","year":"2013","unstructured":"Chung WH, Shih SR, Chang CF et al (2013) Clinicopathologic analysis of coxsackievirus a6 new variant induced widespread mucocutaneous bullous reactions mimicking severe cutaneous adverse reactions. J Infect Dis 208(12):1968\u20131978. https:\/\/doi.org\/10.1093\/infdis\/jit383","journal-title":"J Infect Dis"},{"issue":"2","key":"3_CR13","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.jaad.2014.06.026","volume":"72","author":"TN Canavan","year":"2015","unstructured":"Canavan TN, Mathes EF, Frieden I et al (2015) Mycoplasma pneumoniae-induced rash and mucositis as a syndrome distinct from Stevens-Johnson syndrome and erythema multiforme: a systematic review. J Am Acad Dermatol 72(2):239\u2013245. https:\/\/doi.org\/10.1016\/j.jaad.2014.06.026","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"3_CR14","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1016\/j.jaad.2019.06.008","volume":"81","author":"M Herold","year":"2019","unstructured":"Herold M, Nielson CB, Braswell D et al (2019) Clinicopathologic comparison of Rowell syndrome, erythema multiforme, and subacute cutaneous lupus erythematosus. J Am Acad Dermatol 81(6):1435\u20131438. https:\/\/doi.org\/10.1016\/j.jaad.2019.06.008","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"3_CR15","doi-asserted-by":"publisher","first-page":"e431","DOI":"10.1097\/BCR.0000000000000040","volume":"35","author":"FI Macedo","year":"2014","unstructured":"Macedo FI, Faris J, Lum LG et al (2014) Extensive toxic epidermal necrolysis versus acute graft versus host disease after allogenic hematopoietic stem-cell transplantation: challenges in diagnosis and management. J Burn Care Res 35(6):e431\u2013e435. https:\/\/doi.org\/10.1097\/BCR.0000000000000040","journal-title":"J Burn Care Res"},{"issue":"2","key":"3_CR16","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.jaci.2015.05.050","volume":"136","author":"KD White","year":"2015","unstructured":"White KD, Chung WH, Hung SI et al (2015) Evolving models of the immunopathogenesis of T cell-mediated drug allergy: the role of host, pathogens, and drug response. J Allergy Clin Immunol 136(2):219\u2013234; quiz 235. https:\/\/doi.org\/10.1016\/j.jaci.2015.05.050","journal-title":"J Allergy Clin Immunol"},{"issue":"6982","key":"3_CR17","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/428486a","volume":"428","author":"WH Chung","year":"2004","unstructured":"Chung WH, Hung SI, Hong HS et al (2004) Medical genetics: a marker for Stevens-Johnson syndrome. Nature 428(6982):486. https:\/\/doi.org\/10.1038\/428486a","journal-title":"Nature"},{"issue":"11","key":"3_CR18","doi-asserted-by":"publisher","first-page":"4134","DOI":"10.1073\/pnas.0409500102","volume":"102","author":"SI Hung","year":"2005","unstructured":"Hung SI, Chung WH, Liou LB et al (2005) HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol. Proc Natl Acad Sci U S A 102(11):4134\u20134139. https:\/\/doi.org\/10.1073\/pnas.0409500102","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"3_CR19","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.immuni.2008.04.020","volume":"28","author":"D Chessman","year":"2008","unstructured":"Chessman D, Kostenko L, Lethborg T et al (2008) Human leukocyte antigen class I-restricted activation of CD8+ T cells provides the immunogenetic basis of a systemic drug hypersensitivity. Immunity 28(6):822\u2013832. https:\/\/doi.org\/10.1016\/j.immuni.2008.04.020","journal-title":"Immunity"},{"issue":"17","key":"3_CR20","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1056\/NEJMoa1213096","volume":"369","author":"FR Zhang","year":"2013","unstructured":"Zhang FR, Liu H, Irwanto A et al (2013) HLA-B*13:01 and the dapsone hypersensitivity syndrome. N Engl J Med 369(17):1620\u20131628. https:\/\/doi.org\/10.1056\/NEJMoa1213096","journal-title":"N Engl J Med"},{"issue":"12","key":"3_CR21","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1111\/j.1528-1167.2010.02766.x","volume":"51","author":"N Kaniwa","year":"2010","unstructured":"Kaniwa N, Saito Y, Aihara M et al (2010) HLA-B*1511 is a risk factor for carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese patients. Epilepsia 51(12):2461\u20132465. https:\/\/doi.org\/10.1111\/j.1528-1167.2010.02766.x","journal-title":"Epilepsia"},{"issue":"1\u20132","key":"3_CR22","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.eplepsyres.2011.08.010","volume":"97","author":"SH Kim","year":"2011","unstructured":"Kim SH, Lee KW, Song WJ et al (2011) Carbamazepine-induced severe cutaneous adverse reactions and HLA genotypes in Koreans. Epilepsy Res 97(1\u20132):190\u2013197. https:\/\/doi.org\/10.1016\/j.eplepsyres.2011.08.010","journal-title":"Epilepsy Res"},{"issue":"1","key":"3_CR23","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/j.1742-7843.2012.00868.x","volume":"111","author":"YW Shi","year":"2012","unstructured":"Shi YW, Min FL, Qin B et al (2012) Association between HLA and Stevens-Johnson syndrome induced by carbamazepine in Southern Han Chinese: genetic markers besides B*1502? Basic Clin Pharmacol Toxicol 111(1):58\u201364. https:\/\/doi.org\/10.1111\/j.1742-7843.2012.00868.x","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"2","key":"3_CR24","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jdermsci.2013.10.003","volume":"73","author":"YH Hsiao","year":"2014","unstructured":"Hsiao YH, Hui RC, Wu T et al (2014) Genotype-phenotype association between HLA and carbamazepine-induced hypersensitivity reactions: strength and clinical correlations. J Dermatol Sci 73(2):101\u2013109. https:\/\/doi.org\/10.1016\/j.jdermsci.2013.10.003","journal-title":"J Dermatol Sci"},{"issue":"11","key":"3_CR25","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1111\/all.13821","volume":"74","author":"M Mockenhaupt","year":"2019","unstructured":"Mockenhaupt M, Wang CW, Hung SI et al (2019) HLA-B*57:01 confers genetic susceptibility to carbamazepine-induced SJS\/TEN in Europeans. Allergy 74(11):2227\u20132230. https:\/\/doi.org\/10.1111\/all.13821","journal-title":"Allergy"},{"issue":"7","key":"3_CR26","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1111\/epi.12217","volume":"54","author":"YK Cheung","year":"2013","unstructured":"Cheung YK, Cheng SH, Chan EJ et al (2013) HLA-B alleles associated with severe cutaneous reactions to antiepileptic drugs in Han Chinese. Epilepsia 54(7):1307\u20131314. https:\/\/doi.org\/10.1111\/epi.12217","journal-title":"Epilepsia"},{"issue":"3","key":"3_CR27","doi-asserted-by":"publisher","first-page":"349","DOI":"10.2217\/pgs.09.162","volume":"11","author":"SI Hung","year":"2010","unstructured":"Hung SI, Chung WH, Liu ZS et al (2010) Common risk allele in aromatic antiepileptic-drug induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Han Chinese. Pharmacogenomics 11(3):349\u2013356. https:\/\/doi.org\/10.2217\/pgs.09.162","journal-title":"Pharmacogenomics"},{"issue":"5","key":"3_CR28","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1001\/jama.2014.7859","volume":"312","author":"WH Chung","year":"2014","unstructured":"Chung WH, Chang WC, Lee YS, Taiwan Severe Cutaneous Adverse Reaction C, Japan Pharmacogenomics Data Science C et al (2014) Genetic variants associated with phenytoin-related severe cutaneous adverse reactions. JAMA 312(5):525\u2013534. https:\/\/doi.org\/10.1001\/jama.2014.7859","journal-title":"JAMA"},{"issue":"12","key":"3_CR29","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1111\/j.1528-1167.2008.01719.x","volume":"49","author":"C Locharernkul","year":"2008","unstructured":"Locharernkul C, Loplumlert J, Limotai C et al (2008) Carbamazepine and phenytoin induced Stevens-Johnson syndrome is associated with HLA-B*1502 allele in Thai population. Epilepsia 49(12):2087\u20132091. https:\/\/doi.org\/10.1111\/j.1528-1167.2008.01719.x","journal-title":"Epilepsia"},{"issue":"2","key":"3_CR30","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1002\/cpt.1190","volume":"105","author":"SC Su","year":"2019","unstructured":"Su SC, Chen CB, Chang WC et al (2019) HLA alleles and CYP2C9*3 as predictors of phenytoin hypersensitivity in East Asians. Clin Pharmacol Ther 105(2):476\u2013485. https:\/\/doi.org\/10.1002\/cpt.1190","journal-title":"Clin Pharmacol Ther"},{"issue":"11","key":"3_CR31","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.2217\/14622416.9.11.1617","volume":"9","author":"N Kaniwa","year":"2008","unstructured":"Kaniwa N, Saito Y, Aihara M et al (2008) HLA-B locus in Japanese patients with anti-epileptics and allopurinol-related Stevens-Johnson syndrome and toxic epidermal necrolysis. Pharmacogenomics 9(11):1617\u20131622. https:\/\/doi.org\/10.2217\/14622416.9.11.1617","journal-title":"Pharmacogenomics"},{"issue":"5","key":"3_CR32","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1097\/FPC.0b013e32834282b8","volume":"21","author":"HR Kang","year":"2011","unstructured":"Kang HR, Jee YK, Kim YS et al (2011) Positive and negative associations of HLA class I alleles with allopurinol-induced SCARs in Koreans. Pharmacogenet Genomics 21(5):303\u2013307. https:\/\/doi.org\/10.1097\/FPC.0b013e32834282b8","journal-title":"Pharmacogenet Genomics"},{"issue":"9","key":"3_CR33","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1097\/FPC.0b013e328330a3b8","volume":"19","author":"W Tassaneeyakul","year":"2009","unstructured":"Tassaneeyakul W, Jantararoungtong T, Chen P et al (2009) Strong association between HLA-B*5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population. Pharmacogenet Genomics 19(9):704\u2013709. https:\/\/doi.org\/10.1097\/FPC.0b013e328330a3b8","journal-title":"Pharmacogenet Genomics"},{"issue":"9308","key":"3_CR34","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/S0140-6736(02)07873-X","volume":"359","author":"S Mallal","year":"2002","unstructured":"Mallal S, Nolan D, Witt C et al (2002) Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir. Lancet 359(9308):727\u2013732","journal-title":"Lancet"},{"issue":"9312","key":"3_CR35","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/S0140-6736(02)08158-8","volume":"359","author":"S Hetherington","year":"2002","unstructured":"Hetherington S, Hughes AR, Mosteller M et al (2002) Genetic variations in HLA-B region and hypersensitivity reactions to abacavir. Lancet 359(9312):1121\u20131122. https:\/\/doi.org\/10.1016\/S0140-6736(02)08158-8","journal-title":"Lancet"},{"issue":"4","key":"3_CR36","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1016\/j.jaci.2020.08.003","volume":"147","author":"CW Wang","year":"2020","unstructured":"Wang CW, Tassaneeyakul W, Chen CB, Taiwan\/Asian Severe Cutaneous Adverse Reaction C et al (2020) Whole genome sequencing identifies genetic variants associated with co-trimoxazole hypersensitivity in Asians. J Allergy Clin Immunol 147(4):1402\u20131412. https:\/\/doi.org\/10.1016\/j.jaci.2020.08.003","journal-title":"J Allergy Clin Immunol"},{"issue":"8","key":"3_CR37","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1016\/j.jid.2019.12.025","volume":"140","author":"R Nakamura","year":"2020","unstructured":"Nakamura R, Ozeki T, Hirayama N et al (2020) Association of HLA-A*11:01 with sulfonamide-related severe cutaneous adverse reactions in Japanese patients. J Invest Dermatol 140(8):1659\u20131662.e6. https:\/\/doi.org\/10.1016\/j.jid.2019.12.025","journal-title":"J Invest Dermatol"},{"issue":"8","key":"3_CR38","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1097\/FPC.0000000000000153","volume":"25","author":"T Kongpan","year":"2015","unstructured":"Kongpan T, Mahasirimongkol S, Konyoung P et al (2015) Candidate HLA genes for prediction of co-trimoxazole-induced severe cutaneous reactions. Pharmacogenet Genomics 25(8):402\u2013411. https:\/\/doi.org\/10.1097\/FPC.0000000000000153","journal-title":"Pharmacogenet Genomics"},{"issue":"6","key":"3_CR39","doi-asserted-by":"publisher","first-page":"879","DOI":"10.2217\/pgs.10.54","volume":"11","author":"SH Kim","year":"2010","unstructured":"Kim SH, Kim M, Lee KW et al (2010) HLA-B*5901 is strongly associated with methazolamide-induced Stevens-Johnson syndrome\/toxic epidermal necrolysis. Pharmacogenomics 11(6):879\u2013884. https:\/\/doi.org\/10.2217\/pgs.10.54","journal-title":"Pharmacogenomics"},{"issue":"2","key":"3_CR40","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1097\/FPC.0b013e3282f3ef9c","volume":"18","author":"C Lonjou","year":"2008","unstructured":"Lonjou C, Borot N, Sekula P et al (2008) A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs. Pharmacogenet Genomics 18(2):99\u2013107. https:\/\/doi.org\/10.1097\/FPC.0b013e3282f3ef9c","journal-title":"Pharmacogenet Genomics"},{"issue":"5","key":"3_CR41","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1111\/j.1528-1167.2007.01022.x","volume":"48","author":"CB Man","year":"2007","unstructured":"Man CB, Kwan P, Baum L et al (2007) Association between HLA-B*1502 allele and antiepileptic drug-induced cutaneous reactions in Han Chinese. Epilepsia 48(5):1015\u20131018. https:\/\/doi.org\/10.1111\/j.1528-1167.2007.01022.x","journal-title":"Epilepsia"},{"issue":"6","key":"3_CR42","doi-asserted-by":"publisher","first-page":"579","DOI":"10.4103\/0378-6323.57718","volume":"75","author":"TY Mehta","year":"2009","unstructured":"Mehta TY, Prajapati LM, Mittal B et al (2009) Association of HLA-B*1502 allele and carbamazepine-induced Stevens-Johnson syndrome among Indians. Indian J Dermatol Venereol Leprol 75(6):579\u2013582. https:\/\/doi.org\/10.4103\/0378-6323.57718","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"9","key":"3_CR43","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1001\/jamadermatol.2013.4114","volume":"149","author":"W Tangamornsuksan","year":"2013","unstructured":"Tangamornsuksan W, Chaiyakunapruk N, Somkrua R et al (2013) Relationship between the HLA-B*1502 allele and carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis. JAMA Dermatol 149(9):1025\u20131032. https:\/\/doi.org\/10.1001\/jamadermatol.2013.4114","journal-title":"JAMA Dermatol"},{"issue":"9","key":"3_CR44","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1001\/archderm.1987.01660330082014","volume":"123","author":"JC Roujeau","year":"1987","unstructured":"Roujeau JC, Huynh TN, Bracq C et al (1987) Genetic susceptibility to toxic epidermal necrolysis. Arch Dermatol 123(9):1171\u20131173","journal-title":"Arch Dermatol"},{"issue":"11","key":"3_CR45","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1007\/s00228-013-1549-x","volume":"69","author":"C Ciccacci","year":"2013","unstructured":"Ciccacci C, Di Fusco D, Marazzi MC et al (2013) Association between CYP2B6 polymorphisms and Nevirapine-induced SJS\/TEN: a pharmacogenetics study. Eur J Clin Pharmacol 69(11):1909\u20131916. https:\/\/doi.org\/10.1007\/s00228-013-1549-x","journal-title":"Eur J Clin Pharmacol"},{"issue":"4","key":"3_CR46","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1097\/ACI.0b013e3282370c5f","volume":"7","author":"WH Chung","year":"2007","unstructured":"Chung WH, Hung SI, Chen YT (2007) Human leukocyte antigens and drug hypersensitivity. Curr Opin Allergy Clin Immunol 7(4):317\u2013323. https:\/\/doi.org\/10.1097\/ACI.0b013e3282370c5f","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"5005","key":"3_CR47","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/208057a0","volume":"208","author":"CH Schneider","year":"1965","unstructured":"Schneider CH, De Weck AL (1965) A new chemical spect of penicillin allergy: the direct reaction of penicillin with epsilon-amino-groups. Nature 208(5005):57\u201359","journal-title":"Nature"},{"issue":"4","key":"3_CR48","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1097\/00130832-200208000-00003","volume":"2","author":"WJ Pichler","year":"2002","unstructured":"Pichler WJ (2002) Pharmacological interaction of drugs with antigen-specific immune receptors: the p-i concept. Curr Opin Allergy Clin Immunol 2(4):301\u2013305","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"6","key":"3_CR49","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1016\/j.jaci.2011.12.990","volume":"129","author":"CY Wei","year":"2012","unstructured":"Wei CY, Chung WH, Huang HW et al (2012) Direct interaction between HLA-B and carbamazepine activates T cells in patients with Stevens-Johnson syndrome. J Allergy Clin Immunol 129(6):1562\u20131569.e1565. https:\/\/doi.org\/10.1016\/j.jaci.2011.12.990","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"3_CR50","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/j.jaci.2014.09.041","volume":"135","author":"CH Lin","year":"2015","unstructured":"Lin CH, Chen JK, Ko TM et al (2015) Immunologic basis for allopurinol-induced severe cutaneous adverse reactions: HLA-B*58:01-restricted activation of drug-specific T cells and molecular interaction. J Allergy Clin Immunol 135(4):1063\u20131065.e1065. https:\/\/doi.org\/10.1016\/j.jaci.2014.09.041","journal-title":"J Allergy Clin Immunol"},{"issue":"7404","key":"3_CR51","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1038\/nature11147","volume":"486","author":"PT Illing","year":"2012","unstructured":"Illing PT, Vivian JP, Dudek NL et al (2012) Immune self-reactivity triggered by drug-modified HLA-peptide repertoire. Nature 486(7404):554\u2013558. https:\/\/doi.org\/10.1038\/nature11147","journal-title":"Nature"},{"issue":"10","key":"3_CR52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0076211","volume":"8","author":"S Watkins","year":"2013","unstructured":"Watkins S, Pichler WJ (2013) Sulfamethoxazole induces a switch mechanism in T cell receptors containing TCRVbeta20-1, altering pHLA recognition. PLoS One 8(10):e76211. https:\/\/doi.org\/10.1371\/journal.pone.0076211","journal-title":"PLoS One"},{"issue":"6","key":"3_CR53","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1016\/j.jaci.2011.08.013","volume":"128","author":"TM Ko","year":"2011","unstructured":"Ko TM, Chung WH, Wei CY et al (2011) Shared and restricted T-cell receptor use is crucial for carbamazepine-induced Stevens-Johnson syndrome. J Allergy Clin Immunol 128(6):1266\u20131276.e1211. https:\/\/doi.org\/10.1016\/j.jaci.2011.08.013","journal-title":"J Allergy Clin Immunol"},{"issue":"9","key":"3_CR54","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1038\/jid.2015.165","volume":"135","author":"WH Chung","year":"2015","unstructured":"Chung WH, Pan RY, Chu MT et al (2015) Oxypurinol-specific T cells possess preferential TCR clonotypes and express granulysin in allopurinol-induced severe cutaneous adverse reactions. J Invest Dermatol 135(9):2237\u20132248. https:\/\/doi.org\/10.1038\/jid.2015.165","journal-title":"J Invest Dermatol"},{"issue":"3","key":"3_CR55","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.immuni.2012.11.021","volume":"38","author":"K Ladell","year":"2013","unstructured":"Ladell K, Hashimoto M, Iglesias MC et al (2013) A molecular basis for the control of preimmune escape variants by HIV-specific CD8+ T cells. Immunity 38(3):425\u2013436. https:\/\/doi.org\/10.1016\/j.immuni.2012.11.021","journal-title":"Immunity"},{"issue":"12","key":"3_CR56","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1038\/nm.1884","volume":"14","author":"WH Chung","year":"2008","unstructured":"Chung WH, Hung SI, Yang JY et al (2008) Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis. Nat Med 14(12):1343\u20131350. https:\/\/doi.org\/10.1038\/nm.1884","journal-title":"Nat Med"},{"issue":"3","key":"3_CR57","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.jaci.2013.04.036","volume":"132","author":"CW Wang","year":"2013","unstructured":"Wang CW, Chung WH, Cheng YF et al (2013) A new nucleic acid-based agent inhibits cytotoxic T lymphocyte-mediated immune disorders. J Allergy Clin Immunol 132(3):713\u2013722.e711. https:\/\/doi.org\/10.1016\/j.jaci.2013.04.036","journal-title":"J Allergy Clin Immunol"},{"issue":"5388","key":"3_CR58","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1126\/science.282.5388.490","volume":"282","author":"I Viard","year":"1998","unstructured":"Viard I, Wehrli P, Bullani R et al (1998) Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science 282(5388):490\u2013493","journal-title":"Science"},{"issue":"1","key":"3_CR59","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1067\/mai.2002.120563","volume":"109","author":"SJ Posadas","year":"2002","unstructured":"Posadas SJ, Padial A, Torres MJ et al (2002) Delayed reactions to drugs show levels of perforin, granzyme B, and Fas-L to be related to disease severity. J Allergy Clin Immunol 109(1):155\u2013161","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"3_CR60","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1016\/S0002-9440(10)64284-8","volume":"162","author":"R Abe","year":"2003","unstructured":"Abe R, Shimizu T, Shibaki A et al (2003) Toxic epidermal necrolysis and Stevens-Johnson syndrome are induced by soluble Fas ligand. Am J Pathol 162(5):1515\u20131520. https:\/\/doi.org\/10.1016\/S0002-9440(10)64284-8","journal-title":"Am J Pathol"},{"issue":"6","key":"3_CR61","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1038\/nri3839","volume":"15","author":"I Voskoboinik","year":"2015","unstructured":"Voskoboinik I, Whisstock JC, Trapani JA (2015) Perforin and granzymes: function, dysfunction and human pathology. Nat Rev Immunol 15(6):388\u2013400. https:\/\/doi.org\/10.1038\/nri3839","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"3_CR62","doi-asserted-by":"publisher","first-page":"5243","DOI":"10.4049\/jimmunol.174.9.5243","volume":"174","author":"A Deng","year":"2005","unstructured":"Deng A, Chen S, Li Q et al (2005) Granulysin, a cytolytic molecule, is also a chemoattractant and proinflammatory activator. J Immunol 174(9):5243\u20135248","journal-title":"J Immunol"},{"issue":"7","key":"3_CR63","doi-asserted-by":"publisher","first-page":"514","DOI":"10.7326\/0003-4819-151-7-200910060-00016","volume":"151","author":"R Abe","year":"2009","unstructured":"Abe R, Yoshioka N, Murata J et al (2009) Granulysin as a marker for early diagnosis of the Stevens-Johnson syndrome. Ann Intern Med 151(7):514\u2013515","journal-title":"Ann Intern Med"},{"issue":"11","key":"3_CR64","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1111\/ijd.13350","volume":"55","author":"M Weinborn","year":"2016","unstructured":"Weinborn M, Barbaud A, Truchetet F et al (2016) Histopathological study of six types of adverse cutaneous drug reactions using granulysin expression. Int J Dermatol 55(11):1225\u20131233. https:\/\/doi.org\/10.1111\/ijd.13350","journal-title":"Int J Dermatol"},{"issue":"16","key":"3_CR65","doi-asserted-by":"publisher","first-page":"22257","DOI":"10.18632\/oncotarget.8076","volume":"7","author":"HC Hsu","year":"2016","unstructured":"Hsu HC, Thiam TK, Lu YJ et al (2016) Mutations of KRAS\/NRAS\/BRAF predict cetuximab resistance in metastatic colorectal cancer patients. Oncotarget 7(16):22257\u201322270. https:\/\/doi.org\/10.18632\/oncotarget.8076","journal-title":"Oncotarget"},{"issue":"3","key":"3_CR66","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1016\/j.jaip.2020.09.048","volume":"9","author":"CB Chen","year":"2021","unstructured":"Chen CB, Kuo KL, Wang CW et al (2021) Detecting lesional granulysin levels for rapid diagnosis of cytotoxic T lymphocyte-mediated bullous skin disorders. J Allergy Clin Immunol Pract 9(3):1327\u20131337.e1323. https:\/\/doi.org\/10.1016\/j.jaip.2020.09.048","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"18","key":"3_CR67","doi-asserted-by":"publisher","first-page":"3465","DOI":"10.1182\/blood-2010-03-273953","volume":"116","author":"P Tewary","year":"2010","unstructured":"Tewary P, Yang D, de la Rosa G et al (2010) Granulysin activates antigen-presenting cells through TLR4 and acts as an immune alarmin. Blood 116(18):3465\u20133474. https:\/\/doi.org\/10.1182\/blood-2010-03-273953","journal-title":"Blood"},{"key":"3_CR68","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1146\/annurev.immunol.23.021704.115526","volume":"23","author":"LL Lanier","year":"2005","unstructured":"Lanier LL (2005) NK cell recognition. Annu Rev Immunol 23:225\u2013274. https:\/\/doi.org\/10.1146\/annurev.immunol.23.021704.115526","journal-title":"Annu Rev Immunol"},{"issue":"3","key":"3_CR69","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.jaci.2009.10.030","volume":"125","author":"E Morel","year":"2010","unstructured":"Morel E, Escamochero S, Cabanas R et al (2010) CD94\/NKG2C is a killer effector molecule in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis. J Allergy Clin Immunol 125(3):703\u2013710, 710.e701-710.e708. https:\/\/doi.org\/10.1016\/j.jaci.2009.10.030","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"3_CR70","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/j.jid.2016.11.034","volume":"137","author":"SC Su","year":"2017","unstructured":"Su SC, Mockenhaupt M, Wolkenstein P et al (2017) Interleukin-15 is associated with severity and mortality in Stevens-Johnson syndrome\/toxic epidermal necrolysis. J Invest Dermatol 137(5):1065\u20131073. https:\/\/doi.org\/10.1016\/j.jid.2016.11.034","journal-title":"J Invest Dermatol"},{"issue":"1","key":"3_CR71","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/sj.cr.7290259","volume":"15","author":"ZG Liu","year":"2005","unstructured":"Liu ZG (2005) Molecular mechanism of TNF signaling and beyond. Cell Res 15(1):24\u201327. https:\/\/doi.org\/10.1038\/sj.cr.7290259","journal-title":"Cell Res"},{"issue":"5","key":"3_CR72","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1001\/archderm.1994.01690050073012","volume":"130","author":"P Paquet","year":"1994","unstructured":"Paquet P, Nikkels A, Arrese JE et al (1994) Macrophages and tumor necrosis factor alpha in toxic epidermal necrolysis. Arch Dermatol 130(5):605\u2013608","journal-title":"Arch Dermatol"},{"issue":"4","key":"3_CR73","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1111\/j.1365-2133.1996.tb06976.x","volume":"134","author":"C Paul","year":"1996","unstructured":"Paul C, Wolkenstein P, Adle H et al (1996) Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis. Br J Dermatol 134(4):710\u2013714","journal-title":"Br J Dermatol"},{"issue":"2","key":"3_CR74","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/jid.2012.330","volume":"133","author":"I Viard-Leveugle","year":"2013","unstructured":"Viard-Leveugle I, Gaide O, Jankovic D et al (2013) TNF-alpha and IFN-gamma are potential inducers of Fas-mediated keratinocyte apoptosis through activation of inducible nitric oxide synthase in toxic epidermal necrolysis. J Invest Dermatol 133(2):489\u2013498. https:\/\/doi.org\/10.1038\/jid.2012.330","journal-title":"J Invest Dermatol"},{"issue":"5","key":"3_CR75","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/j.jid.2016.11.034","volume":"137","author":"SC Su","year":"2016","unstructured":"Su SC, Mockenhaupt M, Wolkenstein P et al (2016) Interleukin-15 is associated with severity and mortality in Stevens-Johnson syndrome\/toxic epidermal necrolysis. J Invest Dermatol 137(5):1065\u20131073. https:\/\/doi.org\/10.1016\/j.jid.2016.11.034","journal-title":"J Invest Dermatol"},{"issue":"5","key":"3_CR76","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1111\/j.0022-202X.2004.23439.x","volume":"123","author":"A Nassif","year":"2004","unstructured":"Nassif A, Moslehi H, Le Gouvello S et al (2004) Evaluation of the potential role of cytokines in toxic epidermal necrolysis. J Invest Dermatol 123(5):850\u2013855. https:\/\/doi.org\/10.1111\/j.0022-202X.2004.23439.x","journal-title":"J Invest Dermatol"},{"issue":"2","key":"3_CR77","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.jaci.2004.04.034","volume":"114","author":"B Tapia","year":"2004","unstructured":"Tapia B, Padial A, Sanchez-Sabate E, Alvarez-Ferreira J et al (2004) Involvement of CCL27-CCR10 interactions in drug-induced cutaneous reactions. J Allergy Clin Immunol 114(2):335\u2013340. https:\/\/doi.org\/10.1016\/j.jaci.2004.04.034","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"3_CR78","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1067\/mjd.2002.120473","volume":"47","author":"O Correia","year":"2002","unstructured":"Correia O, Delgado L, Barbosa IL et al (2002) Increased interleukin 10, tumor necrosis factor alpha, and interleukin 6 levels in blister fluid of toxic epidermal necrolysis. J Am Acad Dermatol 47(1):58\u201362","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"3_CR79","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1097\/00000372-200010000-00005","volume":"22","author":"P Paquet","year":"2000","unstructured":"Paquet P, Paquet F, Al Saleh W et al (2000) Immunoregulatory effector cells in drug-induced toxic epidermal necrolysis. Am J Dermatopathol 22(5):413\u2013417","journal-title":"Am J Dermatopathol"},{"issue":"4","key":"3_CR80","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1111\/j.1365-2133.2006.07398.x","volume":"155","author":"M Caproni","year":"2006","unstructured":"Caproni M, Torchia D, Schincaglia E et al (2006) Expression of cytokines and chemokine receptors in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome\/toxic epidermal necrolysis. Br J Dermatol 155(4):722\u2013728. https:\/\/doi.org\/10.1111\/j.1365-2133.2006.07398.x","journal-title":"Br J Dermatol"},{"issue":"16","key":"3_CR81","doi-asserted-by":"publisher","first-page":"4023","DOI":"10.1158\/1078-0432.CCR-15-2872","volume":"22","author":"SM Goldinger","year":"2016","unstructured":"Goldinger SM, Stieger P, Meier B et al (2016) Cytotoxic cutaneous adverse drug reactions during anti-PD-1 therapy. Clin Cancer Res 22(16):4023\u20134029. https:\/\/doi.org\/10.1158\/1078-0432.CCR-15-2872","journal-title":"Clin Cancer Res"},{"issue":"12","key":"3_CR82","doi-asserted-by":"publisher","first-page":"2908","DOI":"10.1158\/1078-0432.CCR-15-2412","volume":"22","author":"A Martens","year":"2016","unstructured":"Martens A, Wistuba-Hamprecht K, Geukes Foppen M et al (2016) Baseline peripheral blood biomarkers associated with clinical outcome of advanced melanoma patients treated with ipilimumab. Clin Cancer Res 22(12):2908\u20132918. https:\/\/doi.org\/10.1158\/1078-0432.CCR-15-2412","journal-title":"Clin Cancer Res"},{"issue":"9","key":"3_CR83","first-page":"1041","volume":"126","author":"A Laupacis","year":"1982","unstructured":"Laupacis A, Keown PA, Ulan RA et al (1982) Cyclosporin A: a powerful immunosuppressant. Can Med Assoc J 126(9):1041\u20131046","journal-title":"Can Med Assoc J"},{"issue":"3","key":"3_CR84","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1111\/j.1365-2133.2012.11074.x","volume":"167","author":"HY Lee","year":"2012","unstructured":"Lee HY, Dunant A, Sekula P et al (2012) The role of prior corticosteroid use on the clinical course of Stevens\u2013Johnson syndrome and toxic epidermal necrolysis: a case\u2013control analysis of patients selected from the multinational EuroSCAR and RegiSCAR studies. Br J Dermatol 167(3):555\u2013562. https:\/\/doi.org\/10.1111\/j.1365-2133.2012.11074.x","journal-title":"Br J Dermatol"},{"issue":"3","key":"3_CR85","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1177\/1060028014560012","volume":"49","author":"EH Law","year":"2014","unstructured":"Law EH, Leung M (2014) Corticosteroids in Stevens-Johnson syndrome\/toxic epidermal necrolysis: current evidence and implications for future research. Ann Pharmacother 49(3):335\u2013342. https:\/\/doi.org\/10.1177\/1060028014560012","journal-title":"Ann Pharmacother"},{"issue":"6","key":"3_CR86","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s40264-014-0165-8","volume":"37","author":"RP Dodiuk-Gad","year":"2014","unstructured":"Dodiuk-Gad RP, Chung WH, Yang CH et al (2014) The 8th international congress on cutaneous adverse drug reactions, Taiwan, 2013: focus on severe cutaneous adverse reactions. Drug Saf 37(6):459\u2013464. https:\/\/doi.org\/10.1007\/s40264-014-0165-8","journal-title":"Drug Saf"},{"issue":"3","key":"3_CR87","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1177\/1060028014560012","volume":"49","author":"EH Law","year":"2015","unstructured":"Law EH, Leung M (2015) Corticosteroids in Stevens-Johnson syndrome\/toxic epidermal necrolysis: current evidence and implications for future research. Ann Pharmacother 49(3):335\u2013342. https:\/\/doi.org\/10.1177\/1060028014560012","journal-title":"Ann Pharmacother"},{"issue":"4","key":"3_CR88","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1067\/mjd.2002.127249","volume":"47","author":"P Tristani-Firouzi","year":"2002","unstructured":"Tristani-Firouzi P, Petersen MJ, Saffle JR et al (2002) Treatment of toxic epidermal necrolysis with intravenous immunoglobulin in children. J Am Acad Dermatol 47(4):548\u2013552. https:\/\/doi.org\/10.1067\/mjd.2002.127249","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"3_CR89","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1111\/j.1365-2133.2012.10965.x","volume":"167","author":"YC Huang","year":"2012","unstructured":"Huang YC, Li YC, Chen TJ (2012) The efficacy of intravenous immunoglobulin for the treatment of toxic epidermal necrolysis: a systematic review and meta-analysis. Br J Dermatol 167(2):424\u2013432. https:\/\/doi.org\/10.1111\/j.1365-2133.2012.10965.x","journal-title":"Br J Dermatol"},{"issue":"5","key":"3_CR90","first-page":"515","volume":"151","author":"YC Huang","year":"2016","unstructured":"Huang YC, Chien YN, Chen YT et al (2016) Intravenous immunoglobulin for the treatment of toxic epidermal necrolysis: a systematic review and meta-analysis. G Ital Dermatol Venereol 151(5):515\u2013524","journal-title":"G Ital Dermatol Venereol"},{"issue":"6","key":"3_CR91","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1001\/jamadermatol.2016.5668","volume":"153","author":"S Zimmermann","year":"2017","unstructured":"Zimmermann S, Sekula P, Venhoff M et al (2017) Systemic immunomodulating therapies for Stevens-Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis. JAMA Dermatol 153(6):514\u2013522. https:\/\/doi.org\/10.1001\/jamadermatol.2016.5668","journal-title":"JAMA Dermatol"},{"issue":"2","key":"3_CR92","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.jaad.2020.08.122","volume":"84","author":"TY Tsai","year":"2021","unstructured":"Tsai TY, Huang IH, Chao YC et al (2021) Treating toxic epidermal necrolysis with systemic immunomodulating therapies: a systematic review and network meta-analysis. J Am Acad Dermatol 84(2):390\u2013397. https:\/\/doi.org\/10.1016\/j.jaad.2020.08.122","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"3_CR93","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1111\/j.1365-2230.2010.03826.x","volume":"35","author":"R Rajaratnam","year":"2010","unstructured":"Rajaratnam R, Mann C, Balasubramaniam P et al (2010) Toxic epidermal necrolysis: retrospective analysis of 21 consecutive cases managed at a tertiary centre. Clin Exp Dermatol 35(8):853\u2013862. https:\/\/doi.org\/10.1111\/j.1365-2230.2010.03826.x","journal-title":"Clin Exp Dermatol"},{"key":"3_CR94","doi-asserted-by":"publisher","unstructured":"Valeyrie-Allanore L, Wolkenstein P, Brochard L, Ortonne N, Ma\u00eetre B, Revuz J, Bagot M, Roujeau JC (2010) Open trial of ciclosporin treatment for Stevens\u2013Johnson syndrome and toxic epidermal necrolysis. Br J Dermatol 163(4):847\u2013853. https:\/\/doi.org\/10.1111\/j.1365-2133.2010.09863.x","DOI":"10.1111\/j.1365-2133.2010.09863.x"},{"issue":"5","key":"3_CR95","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.jaad.2014.07.016","volume":"71","author":"MG Kirchhof","year":"2014","unstructured":"Kirchhof MG, Miliszewski MA, Sikora S et al (2014) Retrospective review of Stevens-Johnson syndrome\/toxic epidermal necrolysis treatment comparing intravenous immunoglobulin with cyclosporine. J Am Acad Dermatol 71(5):941\u2013947. https:\/\/doi.org\/10.1016\/j.jaad.2014.07.016","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"3_CR96","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.jaad.2016.07.048","volume":"76","author":"HY Lee","year":"2017","unstructured":"Lee HY, Fook-Chong S, Koh HY et al (2017) Cyclosporine treatment for Stevens-Johnson syndrome\/toxic epidermal necrolysis: retrospective analysis of a cohort treated in a specialized referral center. J Am Acad Dermatol 76(1):106\u2013113. https:\/\/doi.org\/10.1016\/j.jaad.2016.07.048","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"3_CR97","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1016\/j.jid.2017.05.022","volume":"137","author":"C Gonz\u00e1lez-Herrada","year":"2017","unstructured":"Gonz\u00e1lez-Herrada C, Rodr\u00edguez-Mart\u00edn S, Cachafeiro L et al (2017) Cyclosporine use in epidermal necrolysis is associated with an important mortality reduction: evidence from three different approaches. J Investig Dermatol 137(10):2092\u20132100. https:\/\/doi.org\/10.1016\/j.jid.2017.05.022","journal-title":"J Investig Dermatol"},{"issue":"6","key":"3_CR98","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.jid.2017.12.034","volume":"138","author":"F Poizeau","year":"2018","unstructured":"Poizeau F, Gaudin O, Le Cleach L et al (2018) Cyclosporine for epidermal necrolysis: absence of beneficial effect in a retrospective cohort of 174 patients exposed\/unexposed and propensity score-matched analyses. J Investig Dermatol 138(6):1293\u20131300. https:\/\/doi.org\/10.1016\/j.jid.2017.12.034","journal-title":"J Investig Dermatol"},{"issue":"9140","key":"3_CR99","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1016\/S0140-6736(98)02197-7","volume":"352","author":"P Wolkenstein","year":"1998","unstructured":"Wolkenstein P, Latarjet J, Roujeau JC et al (1998) Randomised comparison of thalidomide versus placebo in toxic epidermal necrolysis. Lancet 352(9140):1586\u20131589. https:\/\/doi.org\/10.1016\/S0140-6736(98)02197-7","journal-title":"Lancet"},{"issue":"10","key":"3_CR100","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1111\/j.1346-8138.2010.00893.x","volume":"37","author":"B Kreft","year":"2010","unstructured":"Kreft B, Wohlrab J, Bramsiepe I et al (2010) Etoricoxib-induced toxic epidermal necrolysis: successful treatment with infliximab. J Dermatol 37(10):904\u2013906. https:\/\/doi.org\/10.1111\/j.1346-8138.2010.00893.x","journal-title":"J Dermatol"},{"issue":"8","key":"3_CR101","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1111\/j.1365-2230.2012.04357.x","volume":"37","author":"F Worsnop","year":"2012","unstructured":"Worsnop F, Wee J, Natkunarajah J et al (2012) Reaction to biological drugs: infliximab for the treatment of toxic epidermal necrolysis subsequently triggering erosive lichen planus. Clin Exp Dermatol 37(8):879\u2013881. https:\/\/doi.org\/10.1111\/j.1365-2230.2012.04357.x","journal-title":"Clin Exp Dermatol"},{"issue":"3","key":"3_CR102","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1111\/j.1346-8138.2009.00616.x","volume":"36","author":"E Gubinelli","year":"2009","unstructured":"Gubinelli E, Canzona F, Tonanzi T et al (2009) Toxic epidermal necrolysis successfully treated with etanercept. J Dermatol 36(3):150\u2013153. https:\/\/doi.org\/10.1111\/j.1346-8138.2009.00616.x","journal-title":"J Dermatol"},{"issue":"2","key":"3_CR103","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.jaad.2014.04.044","volume":"71","author":"A Paradisi","year":"2014","unstructured":"Paradisi A, Abeni D, Bergamo F et al (2014) Etanercept therapy for toxic epidermal necrolysis. J Am Acad Dermatol 71(2):278\u2013283. https:\/\/doi.org\/10.1016\/j.jaad.2014.04.044","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"3_CR104","doi-asserted-by":"publisher","first-page":"e83","DOI":"10.1111\/jdv.13330","volume":"30","author":"D Didona","year":"2016","unstructured":"Didona D, Paolino G, Garcovich S et al (2016) Successful use of etanercept in a case of toxic epidermal necrolysis induced by rituximab. J Eur Acad Dermatol Venereol 30(10):e83\u2013e84. https:\/\/doi.org\/10.1111\/jdv.13330","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"3_CR105","doi-asserted-by":"publisher","DOI":"10.7812\/TPP\/16-060","volume":"21","author":"I Chong","year":"2017","unstructured":"Chong I, Chao A (2017) Stevens-Johnson syndrome\/toxic epidermal necrolysis and treatment with a biologic: a case report. Perm J 21:16-060. https:\/\/doi.org\/10.7812\/TPP\/16-060","journal-title":"Perm J"},{"issue":"3","key":"3_CR106","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1172\/JCI93349","volume":"128","author":"C-W Wang","year":"2018","unstructured":"Wang C-W, Yang L-Y, Chen C-B et al (2018) Randomized, controlled trial of TNF-\u03b1 antagonist in CTL-mediated severe cutaneous adverse reactions. J Clin Invest 128(3):985\u2013996. https:\/\/doi.org\/10.1172\/JCI93349","journal-title":"J Clin Invest"},{"issue":"5","key":"3_CR107","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/j.jid.2017.01.003","volume":"137","author":"RS Stern","year":"2017","unstructured":"Stern RS, Divito SJ (2017) Stevens-Johnson syndrome and toxic epidermal necrolysis: associations, outcomes, and pathobiology-thirty years of progress but still much to be done. J Invest Dermatol 137(5):1004\u20131008. https:\/\/doi.org\/10.1016\/j.jid.2017.01.003","journal-title":"J Invest Dermatol"},{"issue":"2","key":"3_CR108","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/s41591-019-0733-7","volume":"26","author":"D Kim","year":"2020","unstructured":"Kim D, Kobayashi T, Voisin B et al (2020) Targeted therapy guided by single-cell transcriptomic analysis in drug-induced hypersensitivity syndrome: a case report. Nat Med 26(2):236\u2013243. https:\/\/doi.org\/10.1038\/s41591-019-0733-7","journal-title":"Nat Med"},{"issue":"1","key":"3_CR109","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jaip.2017.11.023","volume":"6","author":"KD White","year":"2018","unstructured":"White KD, Abe R, Ardern-Jones M et al (2018) SJS\/TEN 2017: building multidisciplinary networks to drive science and translation. J Allergy Clin Immunol Pract 6(1):38\u201369. https:\/\/doi.org\/10.1016\/j.jaip.2017.11.023","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"1","key":"3_CR110","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.jdermsci.2020.02.003","volume":"98","author":"WC Chang","year":"2020","unstructured":"Chang WC, Abe R, Anderson P et al (2020) SJS\/TEN 2019: from science to translation. J Dermatol Sci 98(1):2\u201312. https:\/\/doi.org\/10.1016\/j.jdermsci.2020.02.003","journal-title":"J Dermatol Sci"}],"container-title":["Methods in Molecular Biology","Systems Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-2265-0_3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,19]],"date-time":"2022-04-19T16:11:30Z","timestamp":1650384690000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-2265-0_3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"ISBN":["9781071622643","9781071622650"],"references-count":110,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-2265-0_3","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022]]},"assertion":[{"value":"19 April 2022","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}